The significance of ANXA7 expression and its correlation with poor cellular differentiation and enhanced metastatic potential of gastric cancer

Journal of Surgical Oncology

Volumn 97, Issue 7, 2008, Pages 609-614

  Hsu, Ping I ^a   Huang, Ming Shyan ^b   Chen, Hui Chun ^c   Hsu, Ping Ning ^d   Lai, Tsung Ching ^e   Wang, Jui Ling ^e   Lo, Gin Ho ^a   Lai, Kwok Hung ^a   Tseng, Ching Jiunn ^f   Hsiao, Michael ^e  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e GENOMICS RESEARCH CENTER   (Taiwan)

^f KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

ANXA7; Differentiation; Gastric cancer; Metastasis; Prognosis

Indexed keywords

SYNEXIN;

ARTICLE; CANCER GROWTH; CANCER SURVIVAL; DISTANT METASTASIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JAPAN; KAPLAN MEIER METHOD; LAUREN CLASSIFICATION; MAJOR CLINICAL STUDY; METASTASIS POTENTIAL; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; STOMACH ADENOCARCINOMA; TUMOR CLASSIFICATION; TUMOR DIFFERENTIATION; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ADULT; ANNEXIN A7; CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; STOMACH NEOPLASMS;

EID: 44849138287     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21046     Document Type: Article

References (33)

1. Parkin DM, Bray F, Ferlay J, et al.: Global cancer statistics. CA Cancer J Clin 2005;55:74-108.
2. Chyou PH, Nomura AM, Hankin JH, et al.: A case-cohort study of diet and stomach cancer. Cancer Res 1990;50:7501-7504.
3. El-Omar EM, Carrington M, Chow WH, et al.: Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404:398-402.
4. Inoue M, Tajima K, Hirose K, et al.: Life-style and subsite of gastric cancer - Joint effect of smoking and drinking habits. Int J Cancer 1994;56:494-499.
5. Nomura A, Grove JS, Stemmermann GN, et al.: Cigarette smoking and stomach cancer. Cancer Res 1990;50:7084-7091.
6. Hsu PI, Hwang IR, Cittelly D, et al.: Clinical presentation in relation to diversity within the Helicobacter pylori cag pathogenicity island. Am J Gastroenterol 2002;97:2231-2238.
7. Hsu PI, Lai KH, Chien EJ, et al.: Impact of bacterial eradication on the cell proliferation and p53 protein accumulation in Helicobacter pylori-associated gastritis. Anticancer Res 2000;20:1221-1228.
8. Parsonnet J, Friedman GD, Vandersteen DP, et al.: Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-1131.
9. Watanabe T, Tada M, Nagai H, et al.: Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology 1998;115:642-648.
10. Thompson GB, van Heerden JA, Sarr MG: Adenocarcinoma of the stomach: Are we making progress? Lancet 1993;342:713-718.
11. Lauren P: The two histological main types of gastric carcinoma. Diffuse and so-called intestinal type carcinoma. An attempt at histoclinical classification. Acta Pathol Microbiol Scand 1965;64:31-49.
12. Tahra E: Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol 1993;119:265-272.
13. Solcia E, Fiocca R, Luinetti O, et al.: Intestinal and diffuse gastric cancers arise in a different background of Helicobacter pylori gastritis through different gene involvement. Am J Surg P 1996;20:S8-S22.
14. Wu MS, Shun CT, Wang HP, et al.: Genetic alterations in gastric cancer: Relation to histological subtypes, tumor stage, and Helicobacter pvlori infection. Gastroenterology 1997;112:1457-1465.
15. Chen HC, Chu RY, Hsu PN, et al.: Loss of E-cadherin expression correlates with poor differentiation and invasion into adjacent organs in gastric adenocarcinomas. Cancer Lett 2003;201:97-106.
16. Wu MS, Yang KC, Shun CT, et al.: Distinct clinicopathologic characteristics of diffuse- and intestinal-type gastric cancer in Taiwan. J Clin Gastroenterol 1997;25:646-649.
17. Raynal P, Pollard HB: Annexins: The problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Biochim Biophys Acta 1994;1197:63-93.
18. Nir S, Stutzin A, Pollard HB: Effect of synexin on aggregation and fusion of chromaffin granule ghosts at pH 6. Biochim Biophys Acta 1987;903:309-318.
19. Pollard HB, Rojas E, Burns AL: Synexin (ANXA7) and membrane fusion during the process of exocytotic secretion. Prog Brain Res 1992;92:247-255.
20. Palmer RE, Lee SB, Wong JC, et al.: Induction of BAIAP3 by the EWS-WT1 chimeric fusion implicates regulated exocytosis in tumorigenesis. Cancer Cell 2002;2:497-505.
21. Aaronson SA: Growth factors and cancer. Science 1991;254:1146-1153.
22. Srivastava M, Atwater I, Glasman M, et al.: Defects in inositol 1,4,5-trisphosphate receptor expression, Ca(2+) signaling, and insulin secretion in the ANXA7(+/-) knockout mouse. Proc Natl Acad Sci USA 1999;96:13783-13788.
23. Srivastava M, Montagna C, Leighton X, et al.: Haploinsufficiency of ANXA7 tumor suppressor gene and consequent genomic instability promotes tumorigenesis in the ANXA7(+/-) mouse. Proc Natl Acad Sci USA 2003;100:14287-14292.
24. Srivastava M, Bubendorf L, Srikantan V, et al.: ANXA7, a candidate tumor suppressor gene for prostate cancer. Proc Natl Acad Sci USA 2001;98:4575-4580.
25. Srivastava M, Bubendorf L, Raffeld M, et al.: Prognostic impact of ANXA7-GTPase in metastatic and HER2-negative breast cancer patients. Clin Cancer Res 2004;10:2344-2350.
26. Hung KS, Howng SL: Prognostic significance of ANXA7 expression in glioblastomas multiforme in humans. J Neurosurg 2003;99:886-892.
27. Kajitani T: The general rules for the gastric cancer study in surgery and pathology. Part I: Clinical classification. Jpn J Surg 1981;11:127-139.
28. Japanese Research Society for Gastric Cancer: Japanese classification of gastric cancer. Tokyo: Kanehara; 1995.
29. Bonfils C, Greenwood M, Tsang A: Expression and characterization of a Dictyostelium discoideum annexin. Mol Cell Biochem 1994;139:159-166.
30. Doring V, Veretout F, Albrecht R, et al.: The in vivo role of ANXA7 (synexin): Characterization of an ANXA7-deficient Dictyostelium mutant indicates an involvement in Ca(2+)-regulated processes. J Cell Sci 1995;108:2065-2076.
31. Kataoka TR, Ito A, Asada H, et al.: ANXA7 as a novel marker for invasive phenotype of malignant melanoma. Jpn J Cancer Res 2000;91:75-83.
32. Srivasta M, Torosyan Y, Raffeld M, et al.: ANXA7 expression represents hormone-relevant tumor suppression in different cancers. Int J Cancer 2007;121:2628-2636.
33. Saito H, Fukumoto Y, Osaki T, et al.: Prognostic significance of level and number of lymph node metastases in patients with gastric cancer. Ann Surg Oncol 2007;14:1688-1693.